Companies / Zymeworks Inc. / Activity
Activity — Zymeworks Inc.
51 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Hollywood Mark Executive | Exercise | Common Stock | $0 | +18K +14.56% | 139,033 0.20% of shares | low |
| Jan 12, 2026 | Moore Paul Andrew Executive | Exercise | Common Stock | $0 | +18K +43.74% | 58,057 0.08% of shares | low |
| Jan 5, 2026 | Moore Paul Andrew Executive | Exercise | Common Stock | $0 | +20K +64.08% | 51,212 0.07% of shares | low |
| Jan 5, 2026 | Moore Paul Andrew Executive | Exercise | Common Stock | $0 | +17K +73.58% | 40,501 0.06% of shares | low |
| Jan 12, 2026 | Smith Jeffrey T L Executive | Exercise | Common Stock | $0 | +18K +96.26% | 36,018 0.05% of shares | low |
| Jan 5, 2026 | Smith Jeffrey T L Executive | Exercise | Common Stock | $0 | +20K +224.97% | 28,890 0.04% of shares | low |
| Jan 12, 2026 | Galbraith Kenneth CEO | Exercise | Common Stock | $0 | +64K +33.12% | 257,266 0.36% of shares | low |
| Jan 5, 2026 | Galbraith Kenneth CEO | Exercise | Common Stock | $0 | +67K +42.12% | 224,952 0.32% of shares | low |
| Jan 5, 2026 | Galbraith Kenneth CEO | Exercise | Common Stock | $0 | +48K +35.77% | 180,943 0.25% of shares | low |
| Jan 6, 2026 | Patterson Leone D Executive | Grant | Common Stock | $4.8K | +459 | 459 <0.01% of shares | low |
| Jan 12, 2026 | Hollywood Mark Executive | Sell | Common Stock | $138.8K | -6K -4.40% | 132,913 0.19% of shares | medium |
| Jan 12, 2026 | Smith Jeffrey T L Executive | Sell | Common Stock | $211.1K | -9K -25.85% | 26,708 0.04% of shares | medium |
| Jan 12, 2026 | Moore Paul Andrew Executive | Sell | Common Stock | $216.8K | -10K -16.47% | 48,497 0.07% of shares | medium |
| Jan 5, 2026 | Moore Paul Andrew Executive | Sell | Common Stock | $233.1K | -9K -22.94% | 31,212 0.04% of shares | medium |
| Jan 5, 2026 | Smith Jeffrey T L Executive | Sell | Common Stock | $264.5K | -11K -36.48% | 18,352 0.03% of shares | medium |
| Jan 5, 2026 | Moore Paul Andrew Executive | Sell | Common Stock | $271.6K | -11K -21.13% | 40,391 0.06% of shares | medium |
| Jan 5, 2026 | Galbraith Kenneth CEO | Sell | Common Stock | $568.6K | -23K -12.52% | 158,286 0.22% of shares | medium |
| Jan 12, 2026 | Galbraith Kenneth CEO | Sell | Common Stock | $689.8K | -30K -11.83% | 226,842 0.32% of shares | medium |
| Jan 5, 2026 | Galbraith Kenneth CEO | Sell | Common Stock | $795.2K | -32K -14.09% | 193,266 0.27% of shares | medium |
| Jan 12, 2026 | Hollywood Mark Executive | Grant | Performance Stock Unit | — | +66K | 66,000 0.09% of shares | low |
| Jan 12, 2026 | Hollywood Mark Executive | Grant | Restricted Stock Unit | — | +47K | 47,000 0.07% of shares | low |
| Jan 12, 2026 | Hollywood Mark Executive | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.10% of shares | low |
| Jan 12, 2026 | Hollywood Mark Executive | Exercise | Restricted Stock Unit | — | -18K -33.33% | 35,334 0.05% of shares | low |
| Jan 12, 2026 | Ciongoli Gregory Austin Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Ciongoli Gregory Austin Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Moore Paul Andrew Executive | Grant | Performance Stock Unit | — | +66K | 66,000 0.09% of shares | low |
| Jan 12, 2026 | Moore Paul Andrew Executive | Grant | Restricted Stock Unit | — | +47K | 47,000 0.07% of shares | low |
| Jan 12, 2026 | Moore Paul Andrew Executive | Grant | Stock Option (Right to Buy) | — | +70K | 70,000 0.10% of shares | low |
| Jan 12, 2026 | Moore Paul Andrew Executive | Exercise | Restricted Stock Unit | — | -18K -33.33% | 35,334 0.05% of shares | low |
| Jan 5, 2026 | Moore Paul Andrew Executive | Exercise | Restricted Stock Unit | — | -20K -50.00% | 20,000 0.03% of shares | low |
| Jan 5, 2026 | Moore Paul Andrew Executive | Exercise | Restricted Stock Unit | — | -17K -100.00% | 0 0.00% of shares | low |
| Jan 12, 2026 | Cesano Alessandra Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Cesano Alessandra Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Campoy Carlos Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Campoy Carlos Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Smith Jeffrey T L Executive | Exercise | Restricted Stock Unit | — | -18K -33.33% | 35,334 0.05% of shares | low |
| Jan 5, 2026 | Smith Jeffrey T L Executive | Exercise | Restricted Stock Unit | — | -20K -50.00% | 20,000 0.03% of shares | low |
| Jan 12, 2026 | Landry Robert E Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Landry Robert E Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Galbraith Kenneth CEO | Grant | Performance Stock Unit | — | +222K | 222,000 0.31% of shares | low |
| Jan 12, 2026 | Galbraith Kenneth CEO | Grant | Restricted Stock Unit | — | +144K | 144,000 0.20% of shares | low |
| Jan 12, 2026 | Galbraith Kenneth CEO | Grant | Stock Option (Right to Buy) | — | +216K | 216,000 0.30% of shares | low |
| Jan 12, 2026 | Galbraith Kenneth CEO | Exercise | Restricted Stock Unit | — | -64K -33.33% | 128,000 0.18% of shares | low |
| Jan 5, 2026 | Galbraith Kenneth CEO | Exercise | Restricted Stock Unit | — | -67K -50.00% | 66,668 0.09% of shares | low |
| Jan 5, 2026 | Galbraith Kenneth CEO | Exercise | Restricted Stock Unit | — | -48K -100.00% | 0 0.00% of shares | low |
| Jan 12, 2026 | Neu Kelvin Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Neu Kelvin Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Mahony Susan Director | Grant | Restricted Stock Unit | — | +8K | 7,700 0.01% of shares | low |
| Jan 12, 2026 | Mahony Susan Director | Grant | Stock Option (Right to Buy) | — | +12K | 11,500 0.02% of shares | low |
| Jan 12, 2026 | Cherry Brian N Director | Grant | Restricted Stock Unit | — | +15K | 15,400 0.02% of shares | low |